5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.40▲ | 6.37▲ | 6.34▲ | 6.23▲ | 5.74▲ |
MA10 | 6.40▲ | 6.34▲ | 6.38▲ | 6.12▲ | 6.30▲ |
MA20 | 6.39▲ | 6.39▲ | 6.33▲ | 5.72▲ | 9.47▼ |
MA50 | 6.34▲ | 6.26▲ | 6.19▲ | 6.60▼ | 14.12▼ |
MA100 | 6.38▲ | 6.18▲ | 5.93▲ | 9.77▼ | 23.65▼ |
MA200 | 6.33▲ | 5.86▲ | 5.54▲ | 12.86▼ | 36.31▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▼ | -0.005▼ | -0.008▼ | 0.187▲ | -0.035▼ |
RSI | 57.700▲ | 55.977▲ | 56.851▲ | 57.572▲ | 33.912▼ |
STOCH | 49.020 | 60.482 | 40.865 | 74.186 | 22.310 |
WILL %R | -35.294 | -13.333▲ | -43.750 | -10.703▲ | -75.075▼ |
CCI | 51.800 | 67.889 | 41.667 | 102.292▲ | -42.907 |
CDL | $PRTA Engulfing Candlestick Pattern Detected | Set Alert |
Tuesday, June 17, 2025 10:30 AM
Prothena Corporation plc (NASDAQ:PRTA) is among the best NASDAQ stocks under $50 to buy. Roche, a partner of Prothena Corporation plc (NASDAQ:PRTA), has announced plans to initiate Phase 3 development ...
|
Monday, June 16, 2025 06:52 PM
Roche, a partner of Prothena Corporation plc (NASDAQ:PRTA), has announced plans to initiate Phase 3 development of prasinezumab for early-stage Parkinson’s disease. Although the company faced a ...
|
Friday, June 06, 2025 07:40 AM
Chardan slashed the firm’s price target on Prothena Corporation plc (NASDAQ:PRTA) on May 27, lowering it to $18 from $40 while maintaining a Buy rating on the shares. Although the firm is ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
03/07/25 | 6.345 | 6.44 | 6.215 | 6.41 | 500,832 |
02/07/25 | 6.25 | 6.585 | 6.13 | 6.32 | 1,114,647 |
01/07/25 | 6.06 | 6.49 | 5.96 | 6.26 | 1,508,083 |
30/06/25 | 6.09 | 6.24 | 6.06 | 6.07 | 1,139,529 |
27/06/25 | 6.25 | 6.41 | 6.01 | 6.08 | 2,692,955 |
26/06/25 | 6.01 | 6.325 | 5.83 | 6.18 | 2,128,907 |
25/06/25 | 6.14 | 6.14 | 5.84 | 5.99 | 1,200,775 |
24/06/25 | 6.14 | 6.28 | 5.86 | 6.07 | 1,636,002 |
23/06/25 | 5.70 | 6.36 | 5.70 | 6.06 | 2,452,348 |
20/06/25 | 5.92 | 6.05 | 5.64 | 5.72 | 3,572,545 |
|
|
||||
|
|
||||
|
|